STOCK TITAN

VEON Ltd. (VEON) SEC Filings, Aug 2025-Feb 2026

VEON NASDAQ

VEON Ltd. filings document the regulatory record of a foreign private issuer with Nasdaq-listed American depositary shares. The company furnishes Form 6-K current reports for press releases and material events, and files Form 20-F annual reports covering audited financial statements, operating performance, business strategy, governance, sustainability and risk disclosures.

Recent filings record annual general meeting materials, board nominations and director elections, ADS depositary fee matters, capital-structure and capital allocation disclosures, integrated annual report publication and subsidiary transactions such as Kyivstar digital-service acquisitions. The filings also provide formal disclosure around VEON's connectivity and digital-services operations.

Rhea-AI Summary

VEON Ltd., through its subsidiary Kyivstar Group Ltd., has completed the acquisition of 100% of Ukrainian digital healthcare platform Tabletki.ua for USD 160 million, payable in Ukrainian hryvna in Ukraine.

Tabletki.ua is a leading Ukrainian platform for finding, comparing, and reserving medicines, partnering with more than 14,000 pharmacies and handling an average of 14 million reservations per month in 2025. Bookings through the platform reached gross merchandise value of UAH 45 billion (USD 1.06 billion) in FY2024 and UAH 57.3 billion (USD 1.19 billion) for the twelve months ending September 30, 2025. Based on unaudited management accounts as of September 30, 2025, Tabletki.ua generated EBITDA of USD 24 million and net profit of USD 20 million, implying a price-to-earnings multiple of 8.0x. The business will join Kyivstar’s broader digital ecosystem, which includes the Helsi e-health platform, Uklon, Kyivstar TV and the MyKyivstar super-app, supporting VEON and Kyivstar’s broader plan to invest USD 1 billion in Ukraine between 2023-2027.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.61%
Tags
current report
-
Rhea-AI Summary

VEON Ltd. has furnished a report highlighting that Kyivstar Group Ltd. has priced a secondary public offering of common shares held by existing shareholders. The offering covers 12,100,000 common shares held by VEON Amsterdam B.V. and 400,000 common shares held by other selling shareholders at a public price of USD 10.50 per share.

The selling shareholders have granted underwriters a 30-day option to purchase up to an additional 1,875,000 common shares at the same public price, less underwriting discounts and commissions. Kyivstar itself is not selling any shares, and the offering is expected to close on February 2, 2026, subject to customary conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.94%
Tags
current report
-
Rhea-AI Summary

VEON Ltd. filed a report highlighting a proposed public offering of Kyivstar Group Ltd. shares by VEON Amsterdam B.V. and other selling shareholders, following Kyivstar’s Form F-1 registration in the United States.

Kyivstar also shared preliminary, unaudited estimates for 2025. Management currently expects revenue growth in U.S. dollars between 24% and 26% year over year, with Adjusted EBITDA growth in the same 24%–26% range. Capex Intensity for 2025 is estimated between 29% and 31%. These figures are based on incomplete closing procedures, have not been audited or reviewed by UHY LLP, and may change. The filing includes extensive forward‑looking statements language, emphasizing uncertainties tied to the ongoing war in Ukraine, sanctions, regulatory constraints, and Kyivstar’s reliance on JSC Kyivstar for distributions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
current report
Form 6-K
Rhea-AI Summary

VEON Ltd. filed a Form 6-K as a foreign private issuer, notifying investors that it has published unaudited interim condensed consolidated financial statements. These statements cover VEON’s results as of, and for, the nine- and three-month periods ended September 30, 2025. The financial statements are provided as Exhibit 99.1 to the report, giving investors updated interim financial information for the year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
current report
-
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.85%
Tags
current report
-
Rhea-AI Summary

VEON Ltd. filed a Form 6-K as a foreign private issuer, primarily to furnish materials released on November 10, 2025. The submission includes a press release, a set of presentation materials, and a supplemental factbook, attached as Exhibits 99.1, 99.2, and 99.3.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.77%
Tags
current report
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.22%
Tags
current report
-
Form 6-K
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.33%
Tags
current report
-
Rhea-AI Summary

VEON Ltd., a foreign private issuer based in Dubai, submitted a Form 6-K for August 2025. The report highlights that on August 28, 2025, VEON and Kyivstar Group Ltd. issued a joint press release and investor presentation related to an investor meeting. These materials provide a corporate update on Kyivstar Group and are included as exhibits to the filing. The press release is labeled Exhibit 99.1 and the investor presentation is labeled Exhibit 99.2.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.64%
Tags
current report
Rhea-AI Summary

VEON Ltd. presented unaudited interim condensed consolidated financial statements for the six months ended June 30, 2025 prepared under IFRS in US dollars. The group reported major corporate actions: completion of the sale-and-leaseback of its Pakistan tower portfolio (Deodar) for total consideration recorded at US$547.5 million with lease liabilities of US$633 million; acquisition of Ukrainian ride-hailing platform Uklon for US$158 million; and a business combination to list Kyivstar on Nasdaq via Cohen Circle, with Kyivstar Group filing an F-4 and listing expected in 3Q 2025. VEON syndicated a US$210 million 24-month term loan and completed phases of a US$100 million buyback program, repurchasing 41,633,300 shares for ~US$75 million. Borrowings were US$2,919 million at June 30, 2025 and cash on hand was US$376 million as of July 31, 2025. Management disclosed material uncertainty about going concern driven by the ongoing war in Ukraine, currency risks, tax developments including an adverse Islamabad High Court ruling on PMCL Deodar and related additional tax expense of US$122 million, and negative working capital of US$421 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.70%
Tags
current report

FAQ

How many VEON Ltd. (VEON) SEC filings are available on StockTitan?

StockTitan tracks 56 SEC filings for VEON Ltd. (VEON), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for VEON Ltd. (VEON)?

The most recent SEC filing for VEON Ltd. (VEON) was filed on November 16, 2026.